(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 10.17% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Caredx's revenue in 2025 is $340,826,000.On average, 4 Wall Street analysts forecast CDNA's revenue for 2025 to be $19,622,220,834, with the lowest CDNA revenue forecast at $19,540,144,880, and the highest CDNA revenue forecast at $19,672,679,981. On average, 4 Wall Street analysts forecast CDNA's revenue for 2026 to be $22,243,009,300, with the lowest CDNA revenue forecast at $21,679,868,190, and the highest CDNA revenue forecast at $22,647,001,835.
In 2027, CDNA is forecast to generate $24,084,129,431 in revenue, with the lowest revenue forecast at $23,953,723,408 and the highest revenue forecast at $24,214,535,454.